Applied Therapeutics Inc. (APLT) Price Chart

The visualized price action of Applied Therapeutics (APLT) helps assess margin risks stemming from potential FDA approval delays for tests and a narrow target market. The business relies on the launch of Govorestat and the development of diabetes therapy in the absence of competitors, which constitutes 0.10. However, uncertainty persists due to high capital expenditure and a lack of actual revenue.

Price Chart: Applied Therapeutics Inc. (APLT) for 07/04/2022 - 02/16/2026

Analytical breakdowns and data insights for company appliedtherapeutics.com (APLT)

- stock quotes and analyst forecast:

Stock Price Applied Therapeutics|APLT - Analyst Consensus Forecast

- market capitalization details:

Market Value Applied Therapeutics Inc.|APLT - Full Business Value

- balance sheet equity data:

Net Assets per Single Share Applied Therapeutics|APLT - Company Book Value|Market Cap to Net Assets Ratio appliedtherapeutics.com|APLT - Aggregate Business Assets

- company total debt and liquidity indicators:

Debt to Equity Applied Therapeutics|APLT - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Applied Therapeutics, Inc.|APLT - Company Aggregate Indebtedness|Debts to Book Capitalization Applied Therapeutics Inc.|APLT - Long-Term Debt|Company Short-Term Debts Applied Therapeutics|Quick Ratio appliedtherapeutics.com

- company profitability and valuation multiples indicators:

APLT - Net Financial Result|Projected Future Earnings Applied Therapeutics|APLT - P/E Multiple|Future Price to Earnings Applied Therapeutics|APLT - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Applied Therapeutics Inc.|APLT - Operating income before deduction of amortization|Net earnings per share for the last 12 months Applied Therapeutics|APLT - Earnings per one share for the last 12 months|Quarterly EPS earnings growth appliedtherapeutics.com|APLT - Earnings per share growth rate in current year|Earnings growth forecast for next year Applied Therapeutics

Fundamental company valuation:Applied Therapeutics

Signature product of Applied Therapeutics, Inc.

The price reflects the market consensus regarding the future value of the business, capturing shifts in investor priorities through support and resistance levels. By analyzing the price action of Applied Therapeutics (APLT), one can assess the probability of capitalizing R&D expenditures, where a breakout above local highs signals market confidence in the success of clinical trials and future monopoly profits from the commercialization of orphan drugs.

Competitors of Applied Therapeutics (APLT)